Claudia Gributs

Claudia Gributs, PhD, is a Senior Director in Bioproduct Analytical Development at Eli Lilly and Company. Claudia has 20 years of experience in the biopharmaceutical industry, having held positions in both development and commercial manufacturing at Lilly. Currently, Claudia’s focus is on the development and commercialization of monoclonal antibodies, in particular the design of integrated control strategies and implementation of appropriate analytical and bioanalytical testing. Claudia earned her B.Sc. and Ph.D. in Chemistry at McGill University (Canada).